Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 5 | 2023 | 419 | 1.420 |
Why?
|
| Taste Perception | 1 | 2023 | 3 | 0.900 |
Why?
|
| Sodium Chloride | 1 | 2023 | 16 | 0.890 |
Why?
|
| Cytokines | 2 | 2023 | 107 | 0.850 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2020 | 27 | 0.690 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 22 | 0.670 |
Why?
|
| Potassium | 2 | 2023 | 25 | 0.400 |
Why?
|
| Blood Pressure | 4 | 2023 | 317 | 0.380 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 237 | 0.320 |
Why?
|
| Adult | 7 | 2024 | 5913 | 0.290 |
Why?
|
| Humans | 10 | 2024 | 14537 | 0.280 |
Why?
|
| Tobacco Use | 2 | 2022 | 12 | 0.250 |
Why?
|
| Young Adult | 3 | 2024 | 2498 | 0.250 |
Why?
|
| Patient Health Questionnaire | 1 | 2024 | 3 | 0.240 |
Why?
|
| Anxiety Disorders | 1 | 2024 | 15 | 0.240 |
Why?
|
| Psychometrics | 1 | 2024 | 22 | 0.240 |
Why?
|
| Taste | 1 | 2023 | 3 | 0.230 |
Why?
|
| Potassium Chloride | 1 | 2023 | 4 | 0.230 |
Why?
|
| Sodium | 1 | 2023 | 30 | 0.220 |
Why?
|
| Urban Population | 1 | 2024 | 257 | 0.200 |
Why?
|
| Ventricular Remodeling | 1 | 2022 | 44 | 0.200 |
Why?
|
| Vascular Stiffness | 1 | 2022 | 41 | 0.200 |
Why?
|
| Tobacco | 1 | 2022 | 14 | 0.200 |
Why?
|
| South Africa | 6 | 2024 | 7596 | 0.190 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2020 | 8 | 0.170 |
Why?
|
| Inflammation | 1 | 2020 | 104 | 0.170 |
Why?
|
| African Americans | 1 | 2019 | 47 | 0.170 |
Why?
|
| Lipids | 1 | 2019 | 81 | 0.160 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 96 | 0.160 |
Why?
|
| Female | 6 | 2024 | 9103 | 0.160 |
Why?
|
| Biomarkers | 1 | 2019 | 327 | 0.150 |
Why?
|
| Prospective Studies | 1 | 2019 | 1160 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 176 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 106 | 0.120 |
Why?
|
| Male | 3 | 2022 | 6754 | 0.110 |
Why?
|
| Neoplasms | 1 | 2015 | 147 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 217 | 0.100 |
Why?
|
| Child | 3 | 2022 | 2242 | 0.100 |
Why?
|
| Obesity | 2 | 2022 | 367 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2022 | 1748 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1422 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 1 | 2024 | 11 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2024 | 27 | 0.060 |
Why?
|
| Aged | 2 | 2022 | 1740 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 9 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2023 | 51 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 64 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2022 | 29 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2022 | 4 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 45 | 0.050 |
Why?
|
| Pulse Wave Analysis | 1 | 2022 | 61 | 0.050 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2022 | 108 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2022 | 65 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2022 | 179 | 0.050 |
Why?
|
| Middle Aged | 2 | 2022 | 3601 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 296 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2022 | 967 | 0.040 |
Why?
|
| Risk Factors | 1 | 2022 | 1475 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 1192 | 0.040 |
Why?
|
| Adolescent | 1 | 2024 | 2985 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2015 | 1 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 1 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 2 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 4 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 6 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 13 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 32 | 0.030 |
Why?
|
| Smoking | 1 | 2015 | 100 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 198 | 0.030 |
Why?
|